Wanbury Limited (BSE: 524212)
Health Care · Pharmaceuticals · IN
Rs265.10
+1.26% today · -8.4% 1Y
Wanbury Limited (BSE: 524212) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $96.68M.
Over the last twelve months the share price has lost 8.4%, trading between 162.00 and 360.00.
Tweenvest scores Wanbury Limited across four factors: quality 64/100, value 45/100, growth 57/100. Its strongest factor is quality.
524212 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $96.68M
- Revenue (TTM)
- $69.03M
- P/E
- 16.23
- EPS
- 16.34
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- Rs360.00
- 52-week low
- Rs162.00
- Avg volume (3M)
- —
- Shares outstanding
- 34.89M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF375.40 | +0.43% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.86 | -0.72% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.